Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.34 | 7e-10 |
mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.29 | 4e-09 |
mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.18 | 2e-08 |
mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.19 | 9e-08 |
mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.17 | 2e-07 |
mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.2 | 3e-07 |
mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-07 |
mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.19 | 7e-07 |
mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.18 | 3e-06 |